Pacific Biosciences
PACB
PACB
98 hedge funds and large institutions have $430M invested in Pacific Biosciences in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
-9
Holders Change %
-8.41%
% of All Funds
2.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
14
Increased
42
Reduced
19
Closed
22
Calls
$260K
Puts
$1.95M
Net Calls
-$1.69M
Net Calls Change
-$976K
Top Buyers
| 1 |
CCM
1
Consonance Capital Management
New York
|
$36.2M |
| 2 |
2
BlackRock
New York
|
$49.2M |
| 3 |
NTC
3
North Tide Capital
Boston,
Massachusetts
|
$5.25M |
| 4 |
SFM
4
Soros Fund Management
New York
|
$3.52M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$23.8M |
